GRAIL (GRAL) Competitors $40.29 +0.57 (+1.44%) Closing price 04:00 PM EasternExtended Trading$40.17 -0.12 (-0.29%) As of 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, VCYT, and ARDTShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Ardent Health Option Care Health (NASDAQ:OPCH) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment. Is OPCH or GRAL more profitable? Option Care Health has a net margin of 4.12% compared to GRAIL's net margin of -1,464.53%. Option Care Health's return on equity of 16.90% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.12% 16.90% 7.00% GRAIL -1,464.53%-17.99%-15.02% Do analysts rate OPCH or GRAL? Option Care Health presently has a consensus price target of $35.50, indicating a potential upside of 19.57%. GRAIL has a consensus price target of $31.50, indicating a potential downside of 21.82%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has better earnings and valuation, OPCH or GRAL? Option Care Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.00B0.97$211.82M$1.2423.94GRAIL$125.60M11.54-$2.03B-$60.99-0.66 Does the media favor OPCH or GRAL? In the previous week, GRAIL had 1 more articles in the media than Option Care Health. MarketBeat recorded 7 mentions for GRAIL and 6 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.85 beat GRAIL's score of 1.48 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive GRAIL 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in OPCH or GRAL? 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by company insiders. Comparatively, 1.9% of GRAIL shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryOption Care Health beats GRAIL on 12 of the 15 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45B$3.04B$5.74B$9.51BDividend YieldN/A2.40%4.60%3.99%P/E Ratio-0.6621.1828.1120.03Price / Sales11.54337.65460.63103.88Price / Cash1.4243.2336.5559.01Price / Book0.548.368.655.90Net Income-$2.03B-$55.19M$3.25B$258.66M7 Day Performance14.49%5.89%4.20%2.23%1 Month Performance-12.74%17.63%10.83%12.77%1 Year Performance154.20%5.10%34.67%19.36% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL0.668 of 5 stars$40.29+1.4%$31.50-21.8%+166.0%$1.45B$125.60M-0.661,360Positive NewsOPCHOption Care Health4.5294 of 5 stars$30.68+2.7%$35.50+15.7%-4.9%$5.02B$5.00B24.748,088Positive NewsUpcoming EarningsRDNTRadNet3.7619 of 5 stars$56.59+2.0%$69.60+23.0%-12.0%$4.25B$1.87B-131.6011,021News CoveragePositive NewsBTSGBrightSpring Health Services1.7016 of 5 stars$20.31flat$24.90+22.6%+71.6%$3.57B$11.86B72.5435,000News CoverageUpcoming EarningsSHCSotera Health3.0908 of 5 stars$11.61-1.6%$16.00+37.8%-9.5%$3.30B$1.10B145.143,000News CoveragePositive NewsSGRYSurgery Partners2.6789 of 5 stars$22.47+2.0%$33.56+49.3%-29.2%$2.88B$3.11B-14.6915,000CONConcentra Group Holdings Parent3.2264 of 5 stars$20.23+1.6%$28.50+40.9%N/A$2.59B$1.90B15.0911,250News CoveragePRVAPrivia Health Group4.0861 of 5 stars$20.89+2.1%$28.38+35.9%+0.3%$2.55B$1.80B174.101,140Positive NewsWGSGeneDx3.9458 of 5 stars$82.39-0.2%$92.33+12.1%+140.7%$2.35B$330.14M-58.431,200Upcoming EarningsVCYTVeracyte3.6646 of 5 stars$26.65-1.6%$40.90+53.5%+0.7%$2.09B$445.76M65.00790Positive NewsGap UpARDTArdent Health3.548 of 5 stars$14.51+2.4%$20.67+42.4%-35.5%$2.08B$5.97B8.9024,900 Related Companies and Tools Related Companies Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives GeneDx Alternatives Veracyte Alternatives Ardent Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRAL Stock Alerts